Clorox (CLX) Tops Q1 EPS by 4c, Updates FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads gains as SpaceX, Super Micro results improve AI appetite
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Alphabet shares drop ahead of earnings next week
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Flutter Entertainment to cut up to 1,400 jobs amid UK tax increases
Clorox Reports Q1 Fiscal Year 2018 Results; Updates Fiscal Year 2018 Outlook
November 1, 2017 6:30 AM EDTOAKLAND, Calif., Nov. 1, 2017 /PRNewswire/ -- The Clorox Company (NYSE: CLX) reported sales growth of 4 percent and diluted net earnings per share growth from continuing operations (diluted EPS) of 7 percent for its first quarter of fiscal year 2018, which ended Sept. 30, 2017.
"I'm very pleased with our strong start to the fiscal year. We delivered sales and earnings growth on top of very good results in the year-ago quarter," said Clorox Chairman and CEO Benno Dorer. "Broad-based strength in our business from strong execution of our 2020 Strategy led to sales increases and gross... More



